Statements (15)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
gptkb:monoclonal_antibody |
| gptkbp:ATCCode |
L01XC13
|
| gptkbp:CASNumber |
827031-97-4
|
| gptkbp:developedBy |
gptkb:Genmab
|
| https://www.w3.org/2000/01/rdf-schema#label |
zalutumumab
|
| gptkbp:legalStatus |
investigational
|
| gptkbp:macromoleculeType |
gptkb:IgG1_kappa
|
| gptkbp:routeOfAdministration |
intravenous
|
| gptkbp:synonym |
HuMax-EGFr
|
| gptkbp:target |
gptkb:epidermal_growth_factor_receptor
|
| gptkbp:UNII |
1YQ7F1W1F1
|
| gptkbp:usedFor |
gptkb:cancer
|
| gptkbp:bfsParent |
gptkb:EGFR_inhibitors_(in_colorectal_cancer)
|
| gptkbp:bfsLayer |
7
|